Research Article

Fecal S100A12 as a Biomarker in Behcet’s Disease

Volume: 12 Number: 3 July 1, 2021
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi Cover
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi
PDF Download
EN

Fecal S100A12 as a Biomarker in Behcet’s Disease

Abstract

Background: Gastroinestinal involvement in Behcet’s disease impacts morbidity and mortality. The diagnosis of gastrointestinal disease requires comprehensive evaluation with endoscopic and radiologic examinations which is costly and impractical. A biomarker is essential for non-invasive detection. Fecal S100A12 is an established biomarker in gastrointestinal inflammatory diseases and its serum levels are known to increase in Behcet’s Disease. In this study, we aimed to tests fecal S100A12 levels in Behcet’s patients, its relation with gastrointestinal symptoms to its potential as a biomarker in gastrointestinal involvement. Methods: We prospectively enrolled 48 cases of Behcet’s disease patients fulfilling International Study Group criteria from a university hospital. We excluded patients with other autoimmune conditions, active or recent infection, using NSAIDs and antibiotics. Control group was selected from volunteers who had applied to the rheumatology outpatient clinic. Patients with BD were categorized into 5 groups according to organ involvement. Also we evaluated and recorded disease activity with the BDCAF 2006. Fecal S100A12, fecal calprotectin and acute phase reactants were also collected. Results: Fecal calprotectin levels were six-fold higher in BD than controls (p<0.0001). Fecal S100A12 was also two-fold higher albeit without statistical significance (p=0.132). Fecal calprotectin and fecal S100A12 levels were positively correlated (r:0.530, p<0.0001). Both fecal calprotectin (138.1 μg/g vs 50.1 μg/g, p=0.006).) and fecal S100A12 (48.3 ng/mL vs 19.4 ng/mL, p=0.023) were higher in Behçet's patients with gastrointestinal symptoms compared to those without. Fecal calprotectin and fecal S100A12 levels were not correlated with total BDCAF score, CRP and ESR levels. Conclusion: Fecal S100A12 is correlated with fecal calprotectin and higher in Behcet’s patients with gastrointestinal involvement. This is the first study of fecal S100A12 in Behcet’s disease and its potential use in Behcet’s disease patients with gastrointestinal symptoms.

Keywords

Supporting Institution

Hacettepe University Scientific Research Project Fund.

Project Number

THD-2017-13174

References

  1. 1. Hatemi G, Yazici Y, Yazici H. Behcet's syndrome. Rheum Dis Clin North Am. 2013;39(2):245-61.
  2. 2. Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, et al. Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behcet's Disease. Isr Med Assoc J. 2018;20(8):517-21.
  3. 3. Melikoglu M, Topkarci Z. Is there a relation between clinical disease activity and acute phase response in Behcet's disease? Int J Dermatol. 2014;53(2):250-4.
  4. 4. Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet's disease activity index. Rheumatology (Oxford). 2004;43(1):73-8.
  5. 5. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behcet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999;38(8):728-33.
  6. 6. Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, et al. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome. Rheumatology (Oxford). 1999;38(8):734-6.
  7. 7. Kopec-Medrek M, Widuchowska M, Kucharz EJ. Calprotectin in rheumatic diseases: a review. Reumatologia. 2016;54(6):306-9.
  8. 8. Manolakis AC, Kapsoritakis AN, Tiaka EK, Potamianos SP. Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Dig Dis Sci. 2011;56(6):1601-11.

Details

Primary Language

English

Subjects

Gastroenterology and Hepatology , Rheumatology and Arthritis

Journal Section

Research Article

Authors

Publication Date

July 1, 2021

Submission Date

April 26, 2021

Acceptance Date

June 14, 2021

Published in Issue

Year 2021 Volume: 12 Number: 3

DOI

https://doi.org/10.31067/acusaglik.928333

IZ

https://izlik.org/JA72GF22PL

Cite

RIS / Bibtex
EndNote
Şimşek C, Armağan B, Hymabaccus B, Sarı A, Erden A, Kılıç L, Akdoğan A (July 1, 2021) Fecal S100A12 as a Biomarker in Behcet’s Disease. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 12 3 616–624.

Cited By

The role of neutrophils in the pathogenesis of Behcet's disease

Modern Rheumatology Journal

https://doi.org/10.14412/1996-7012-2022-4-74-79